Dapsone as initial treatment in superficial pemphigus. Report of nine cases

Basset, N.

doi:10.1001/archderm.123.6.783

Cited by 27 publications

(19 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a study of 9 patients, 5 had at least 50% improvement. 64 These patients had low titers or undetectable circulating antibodies. The remaining 4 patients with high titers of antibodies had no response.…”

Section: Pemphigus Foliaceusmentioning

confidence: 98%

Management of autoimmune bullous diseases: Pharmacology and therapeutics

Mutasim

2004

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Section: Pemphigus Foliaceusmentioning

confidence: 98%

Management of autoimmune bullous diseases: Pharmacology and therapeutics

Mutasim

2004

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…[6][7][8][9] To decrease the exposure to corticosteroids, the use of steroid-sparing agents in pemphigus has become common. These agents include azathioprine, 3 cyclosporine, 10,11 gold, 12 dapsone, 13 antimalarials, 14 and cyclophosphamide. 2 However, these treatment modalities may cause adverse reactions of their own.…”

mentioning

confidence: 99%

Pulse Intravenous Cyclophosphamide Therapy in Pemphigus

Fleischli¹,

Valek²,

Pandya³

1999

Arch Dermatol

View full text Add to dashboard Cite

“…Une étude rétrospective portant sur de faibles effectifs suggère son efficacité [8]. Une étude prospective randomisée n'a pas permis de démontrer son intérêt en tant qu'agent d'épargne cortisonique pour le traitement des pemphigus vulgaires [9].…”

Section: Dapsoneunclassified

Pemphigus

Lapeyre-Liénard

Joly

2010

La Presse Médicale

View full text Add to dashboard Cite

Pemphigus is a rare autoimmune blistering disorder involving the skin and mucosae. Three types of pemphigus have been described, including pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. Diagnosis of the type of pemphigus is made by the combination of clinical features, histological and direct immunofluorescence findings, and serum analysis by indirect immunofluorescence, immunoblot analysis and enzyme-linked-immunosorbent-assay (Elisa). Most patients are treated with oral corticosteroids, sometimes associated with immunosuppressants. Patients with treatment failure or with contraindications to systemic corticosteroids and/or immunosuppressants may be treated with intravenous immunoglobulins or rituximab, an anti-CD20 monoclonal antibody.

show abstract

Dapsone as initial treatment in superficial pemphigus. Report of nine cases

Cited by 27 publications

References 0 publications

Management of autoimmune bullous diseases: Pharmacology and therapeutics

Management of autoimmune bullous diseases: Pharmacology and therapeutics

Pulse Intravenous Cyclophosphamide Therapy in Pemphigus

Pemphigus

Contact Info

Product

Resources

About